is being presented by Dr. Tony Lockett, Medical Director, with Information Change Organisation Ltd and airs on Thursday, May 20, 2010. For more details or to register, please visit our site at www.fxconferences.com
Nanotechnology is an emotional subject for a public concerned about the perceived threat from so-called frankenfoods. The initial response from government has been to do nothing specific, and until recently drugs based on nanomaterials were treated as new chemical entities (NCE). This has led to a considerable delay in the development of nanomaterials – particularly those for medical uses, where full toxicological assessment was often required prior to using these materials in humans.
There are signs that this is changing. The realization that many nanoparticles are in fact natural, and that materials can self assemble in biological systems, has forced a change in the way we think about nanotechnology. However, there is widespread concern over development of national policies to control this technology, and many fear local regulation will lead to commercial interests being put before safety and efficacy. They believe transnational regulation is required – similar to that exercised by the International Conference on Harmonization with regard to pharmaceutical development – to counterbalance commercial interests.
This audio conference presentation will provide an overview of current regulations governing nanotechnology, and discuss future regulatory strategies.
